Abstract
The rapid advancement of germline editing techniques holds transformative potential for eradicating heritable disorders. However, this scientific breakthrough presents significant ethical, technical, and regulatory challenges. This paper explores recent developments in germline editing technologies, ethical implications, and regulatory frameworks, with a focus on 2023 advancements. The interplay between these dimensions highlights the complexities of translating germline editing from laboratory research to clinical applications.
View more >>